jhno774
2021-08-26
Nice
Regencell Bioscience reaches a post-IPO peak adding to recent volatility
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
3
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":810374620,"tweetId":"810374620","gmtCreate":1629948534560,"gmtModify":1631892365763,"author":{"id":4091766705369530,"idStr":"4091766705369530","authorId":4091766705369530,"authorIdStr":"4091766705369530","name":"jhno774","avatar":"https://static.tigerbbs.com/1327aebace4dabb0bb59c972fe1f3a85","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Nice</p></body></html>","htmlText":"<html><head></head><body><p>Nice</p></body></html>","text":"Nice","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/810374620","repostId":1177059583,"repostType":4,"repost":{"id":"1177059583","kind":"news","pubTimestamp":1629946158,"share":"https://www.laohu8.com/m/news/1177059583?lang=&edition=full","pubTime":"2021-08-26 10:49","market":"us","language":"en","title":"Regencell Bioscience reaches a post-IPO peak adding to recent volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=1177059583","media":"seekingalpha","summary":"Regencell Bioscience has nearly doubled in value, adding to the recent volatility shown by the Hong ","content":"<ul>\n <li>Regencell Bioscience has nearly doubled in value, adding to the recent volatility shown by the Hong Kong-based company focused on traditional Chinese medicine (TCM).</li>\n <li>In mid-July, Regencell Bioscience(NASDAQ:RGC)went public, targeting to raise $21.9M in gross proceeds with the offering of 2.3M shares at $9.5 apiece. The stock has added ~178.0% since then, including ~204.1% recorded on August 20.</li>\n <li>However, highlighting the volatility, Regencell Bioscience (RGC) fell ~28.3% on Tuesday to post its biggest one-day loss since the public debut.</li>\n <li>Commenting on the IPO, Seeking Alpha contributor Donovan Jones argued that the companies focused on TCM enjoy a large market opportunity in China, which has the potential to grow at a double-digit rate due to the aging population and government backing.</li>\n <li>However, Jones, with a neutral view on Regencell Bioscience (RGC) pointed out that the company needs to differentiate its product offering as it takes on larger and more established players in the TCM market in China.</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regencell Bioscience reaches a post-IPO peak adding to recent volatility</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegencell Bioscience reaches a post-IPO peak adding to recent volatility\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 10:49 GMT+8 <a href=https://seekingalpha.com/news/3734089-regencell-bioscience-reaches-a-post-ipo-peak-adding-to-recent-volatility><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Regencell Bioscience has nearly doubled in value, adding to the recent volatility shown by the Hong Kong-based company focused on traditional Chinese medicine (TCM).\nIn mid-July, Regencell Bioscience(...</p>\n\n<a href=\"https://seekingalpha.com/news/3734089-regencell-bioscience-reaches-a-post-ipo-peak-adding-to-recent-volatility\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RGC":"脑再生科技"},"source_url":"https://seekingalpha.com/news/3734089-regencell-bioscience-reaches-a-post-ipo-peak-adding-to-recent-volatility","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1177059583","content_text":"Regencell Bioscience has nearly doubled in value, adding to the recent volatility shown by the Hong Kong-based company focused on traditional Chinese medicine (TCM).\nIn mid-July, Regencell Bioscience(NASDAQ:RGC)went public, targeting to raise $21.9M in gross proceeds with the offering of 2.3M shares at $9.5 apiece. The stock has added ~178.0% since then, including ~204.1% recorded on August 20.\nHowever, highlighting the volatility, Regencell Bioscience (RGC) fell ~28.3% on Tuesday to post its biggest one-day loss since the public debut.\nCommenting on the IPO, Seeking Alpha contributor Donovan Jones argued that the companies focused on TCM enjoy a large market opportunity in China, which has the potential to grow at a double-digit rate due to the aging population and government backing.\nHowever, Jones, with a neutral view on Regencell Bioscience (RGC) pointed out that the company needs to differentiate its product offering as it takes on larger and more established players in the TCM market in China.","news_type":1},"isVote":1,"tweetType":1,"viewCount":26,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/810374620"}
精彩评论